Transforming growth factor β-1 and interleukin-17 gene transcription in peripheral blood mononuclear cells and the human response to infection

Cytokine

Volumn 50, Issue 3, 2010, Pages 322-327

  White, Mary ^a,c   Lawless, Matthew W ^d   O'Dwyer, Michael J ^a   Grealy, Robert ^a,c   Connell, Brian O ^a   Stordeur, Patrick ^b   Kelleher, Dermot ^c   McManus, Ross ^c   Ryan, Thomas ^a,c  

^a ST JAMES S HOSPITAL   (Ireland)

^b ERASME HOSPITAL   (Belgium)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Cytokine; Infection; Polymerase chain reaction; Sepsis

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

AGED; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSCRIPTION; GRAM NEGATIVE SEPSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; SEPTIC SHOCK;

NEGIBACTERIA;

EID: 77952544328     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.01.003     Document Type: Article

References (27)

1. O'Dwyer M.J., Mankan A.K., Stordeur P., O'Connell B., Duggan E., White M., et al. The occurrence of severe sepsis and septic shock are related to distinct patterns of cytokine gene expression. Shock 2006, 26:544-550.
2. van Dissel J.T., van Langevelde P., Westendorp R.G., Kwappenberg K., Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998, 351:950-953.
3. Westendorp R.G., Langermans J.A., Huizinga T.W., Elouali A.H., Verweij C.L., Boomsma D.I., et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997, 349:170-173.
4. O'Dwyer M.J., Mankan A.K., White M., Lawless M.W., Stordeur P., O'Connell B., et al. The human response to infection is associated with distinct patterns of interleukin 23 and interleukin 27 expression. Intensive Care Med 2008, 34:683-691.
5. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
6. Ye P., Garvey P.B., Zhang P., Nelson S., Bagby G., Summer W.R., et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 2001, 25:335-340.
7. Chen Y., Langrish C.L., McKenzie B., Joyce-Shaikh B., Stumhofer J.S., McClanahan T., et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006, 116:1317-1326.
8. Sutton C., Brereton C., Keogh B., Mills K.H., Lavelle E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006, 203:1685-1691.
9. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006, 24:99-146.
10. Laouar Y., Sutterwala F.S., Gorelik L., Flavell R.A. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol 2005, 6:600-607.
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
12. Le Gall J.R., Lemeshow S., Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
13. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med 1996, 22:707-710.
14. Stordeur P., Poulin L.F., Craciun L., Zhou L., Schandene L., de Lavareille A., et al. Cytokine mRNA quantification by real-time PCR. J Immunol Methods 2002, 259:55-64.
15. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
16. Pachot A., Monneret G., Voirin N., Leissner P., Venet F., Bohe J., et al. Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin Immunol 2005, 114:61-69.
17. Kellum J.A., Kong L., Fink M.P., Weissfeld L.A., Yealy D.M., Pinsky M.R., et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007, 167:1655-1663.
18. Happel K.I., Lockhart E.A., Mason C.M., Porretta E., Keoshkerian E., Odden A.R., et al. Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect Immun 2005, 73:5782-5788.
19. Uhlig H.H., McKenzie B.S., Hue S., Thompson C., Joyce-Shaikh B., Stepankova R., et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006, 25:309-318.
20. Diehl S., Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002, 39:531-536.
21. Diehl S., Anguita J., Hoffmeyer A., Zapton T., Ihle J.N., Fikrig E., et al. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 2000, 13:805-815.
22. Ward P.A. The dark side of C5a in sepsis. Nat Rev Immunol 2004, 4:133-142.
23. Di Santo E., Alonzi T., Poli V., Fattori E., Toniatti C., Sironi M., et al. Differential effects of IL-6 on systemic and central production of TNF: a study with IL-6-deficient mice. Cytokine 1997, 9:300-306.
24. van der Poll T., Keogh C.V., Guirao X., Buurman W.A., Kopf M., Lowry S.F. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 1997, 176:439-444.
25. Goldie A.S., Fearon K.C., Ross J.A., Barclay G.R., Jackson R.E., Grant I.S., et al. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA 1995, 274:172-177.
26. Millo J.L., Schultz M.J., Williams C., Weverling G.J., Ringrose T., Mackinlay C.I., et al. Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia. Intensive Care Med 2004, 30:68-74.
27. Tanabe M., Matsumoto T., Shibuya K., Tateda K., Miyazaki S., Nakane A., et al. Compensatory response of IL-1 gene knockout mice after pulmonary infection with Klebsiella pneumoniae. J Med Microbiol 2005, 54:7-13.